首页> 外文期刊>International archives of allergy and immunology >Suspected Reaction with Cephalosporin May Be a Predictive Factor for beta-Lactam Allergy in Children
【24h】

Suspected Reaction with Cephalosporin May Be a Predictive Factor for beta-Lactam Allergy in Children

机译:疑似与头孢菌素的反应可能是儿童β-内酰胺过敏的预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Most children diagnosed with beta-lactam allergy based only on history are not truly allergic, and mislabeling leads to use of less effective and more costly alternative broader-spectrum antibiotics, significantly increasing drug resistance. Objective: To determine the frequency and risk factors of confirmed allergy in patients with beta-lactam allergy reported by parents or their doctors and evaluate cross-reactivity between beta-lactams in children with confirmed allergy. Method: Sixty-seven children with suspected beta-lactam allergy were evaluated via history, sIgE measurements, skin tests, and drug provocation tests over a period of 5 years. Results: beta-Lactam allergy was confirmed in 10 (14.9%) patients. Six patients had a positive intradermal test result to one or more of the penicillin skin test materials or ceftriaxone, 4 patients with negative skin test results had positive test results with suspected drugs. Age, gender, time interval between evaluation and the initial reaction, personal history of atopy, parental history of drug allergy, reaction type, and multiple drug allergy history were not significantly different between allergic and tolerant patients. For culprit drugs, there was a significant different between the 2 groups; the rate of confirmed diagnosis was significantly higher for cephalosporins such as ceftriaxone, cefuroxime, and cefprozil (p = 0.03). Three patients with allergy to penicillin tolerated cefuroxime; in 4 patients with selective allergy to ceftriaxone tolerated cephalosporins with a dissimilar side chain (cefadroxil, cefuroxime, cefaclor, and cefdinir). Conclusion: Our study indicates that most patients with a suspected beta-lactam allergy tolerated this drug. An appropriate diagnostic allergy workup may prevent the use of less effective and more expensive alternatives. (C) 2018 S. Karger AG, Basel
机译:背景:大多数仅基于历史的β-内酰胺过敏的大多数儿童都没有真正过敏,并且错误标记导致使用更少有效和更昂贵的替代更广泛的抗生素,显着提高耐药性。目的:确定父母或医生β-内酰胺过敏患者患者确诊过敏的频率和风险因素,并评估患儿β-内酰胺与确诊过敏的β-内酰胺的交叉反应。方法:通过历史,SiGe测量,皮肤测试和药物挑毒试验评估六十七种涉及β-内酰胺过敏的儿童。结果:β-内酰胺过敏在10名(14.9%)患者中得到证实。六名患者对一个或多个青霉素皮肤测试材料或头孢菌素皮肤测试材料或头孢曲松患者有4例,阴性皮肤试验结果具有阳性测试结果与疑似药物。年龄,性别,评估之间的时间间隔和初始反应,药物过敏,反应类型和多种药物过敏病史的个人历史,过敏性和耐受性患者之间没有显着差异。对于罪魁祸首药物,2组之间存在显着差异;对于头孢菌素,头孢菌素,头孢呋辛和Cefprozil(P = 0.03),Cephalosporins的确诊诊断率明显高。三个患者对青霉素耐受头孢呋辛的过敏症;在4名患者中,用不同的侧链(头孢氏毒性,头孢呋辛,头孢克勒和Cefdinir)对头孢菌耐受性头孢菌素的选择性过敏头孢菌素。结论:我们的研究表明,大多数患有疑似β-内酰胺过敏的患者耐受这种药物。适当的诊断过敏后处理可能会防止使用更少有效和更昂贵的替代品。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号